Align Acetylornithine aminotransferase; ACOAT; EC 2.6.1.11 (uncharacterized)
to candidate 7025958 Shewana3_3106 beta alanine--pyruvate transaminase (RefSeq)
Query= curated2:Q8TUZ5 (389 letters) >lcl|FitnessBrowser__ANA3:7025958 Shewana3_3106 beta alanine--pyruvate transaminase (RefSeq) Length = 446 Score = 191 bits (486), Expect = 3e-53 Identities = 137/417 (32%), Positives = 212/417 (50%), Gaps = 48/417 (11%) Query: 19 PVTLVPGEGARVWDDEGNEYIDLVAGIAVNVLGHCHPAVVEAVKEQVERLIHCSNLYYNE 78 P L EG D GN+ +D AG+ GH + EAV +Q+ + + + Sbjct: 32 PRLLAQAEGMYYTDINGNKVLDSTAGLWCCNAGHGRREISEAVSKQIREMDYAPSFQMGH 91 Query: 79 PQA-EAARLLAEAAPKDLNKVFFCNSGTESVECAIKLARKF------TGCTKFIAFEGGF 131 P A E A L E +P+ LNKVFF NSG+ESV+ A+K+A + T+FI E G+ Sbjct: 92 PLAFELAERLTELSPEGLNKVFFTNSGSESVDTALKMALCYHRANGQASRTRFIGRELGY 151 Query: 132 HGRTMGALSATWKPEFREPFE-PLVPEFEHVPYG-DVN-----------AVEKAI----- 173 HG G +S R+ F L+ +H+P+ D+ EKA Sbjct: 152 HGVGFGGISVGGLSNNRKAFSGQLLQGVDHLPHTLDIQNSAFSRGLPSLGAEKAEVLEQL 211 Query: 174 -----DDDTAAVIVEPVQGEAGVRIPPEGFLRELRELCDEHGLLLIVDEVQSGMGRTGQF 228 ++ AAVIVEP+ G AGV +PP+G+L+ LRE+ ++G+LLI DEV + GR G Sbjct: 212 VTLHGAENIAAVIVEPMSGSAGVILPPQGYLKRLREITQKYGILLIFDEVITAFGRVGAA 271 Query: 229 FAFEHEDVLPDIVCLAKGL-GGGVPVGATIAREEVAEAFEPGD-------HGSTFGGNPL 280 FA + V+PDI+ AK + G +P+GA ++ + + G HG T+ G+P+ Sbjct: 272 FASQRWGVIPDIITTAKAINNGAIPMGAVFVQDFIHDTCMQGPTELIEFFHGYTYSGHPV 331 Query: 281 ACAAVCAAVSTVLEENLPEAA---ERKGKLAMRILSEAEDVVEEVRGRGLMMGVEV---- 333 A AA A +S E L E + ER + A+ L +V+ ++R GL+ G ++ Sbjct: 332 AAAAALATLSIYENEQLFERSFELERYFEDAVHSLKGLPNVI-DIRNTGLVAGFQLAPNS 390 Query: 334 -GDDERAKDVAREMLDRGALVNVTSGDVIRLVPPLVIGEDELEKALAELADALRASG 389 G +R V +G LV T GD+I + PPL++ + ++++ + L+DA+ A G Sbjct: 391 QGAGKRGYSVFEHCFHQGTLVRAT-GDIIAISPPLIVEKHQIDQIVNSLSDAIHAVG 446 Lambda K H 0.318 0.137 0.405 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 410 Number of extensions: 27 Number of successful extensions: 7 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 3 Number of HSP's successfully gapped: 1 Length of query: 389 Length of database: 446 Length adjustment: 31 Effective length of query: 358 Effective length of database: 415 Effective search space: 148570 Effective search space used: 148570 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 16 ( 7.3 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 41 (21.7 bits) S2: 50 (23.9 bits)
This GapMind analysis is from Aug 03 2021. The underlying query database was built on Aug 03 2021.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see the paper from 2019 on GapMind for amino acid biosynthesis, the paper from 2022 on GapMind for carbon sources, or view the source code, or see changes to Amino acid biosynthesis since the publication.
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory